• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

International Programs

  • Print
  • Share
  • E-mail

Section Contents Menu

FDA Globalization

Latin America

FDA’s bilateral and multilateral interactions with Mexico and the countries of Central America, South America, and the Caribbean are to ensure that the entire range of FDA-regulated products developed, tested, manufactured, grown and/or processed from this region and are exported to the U.S. meet FDA requirements. FDA’s efforts focus primarily on food and animal feed safety protection issues, medical product safety issues, and regulatory oversight of clinical trials, as well as product manufacturing quality. Among the many challenges facing the FDA in the region include the wide geographic diversity and area covered by Latin America, the diversity of product issues and the wide range of sophistication of the regulatory authorities in the region.

__________
 

« Return to International Programs

 

Contact FDA

+506 2519-2224
Fax:301-595-7937
Latin America Office

U.S. Food and Drug Administration

Office of International Programs

Latin America Office

3440 San Jose Place

Washington, DC 20521-3440
-